Catalyst Wire Dossier Catalyst Wire Dossier

Losartan Potassium Tablets, 25 mg

LOSARTAN POTASSIUM · Jubilant Cadista Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Losartan Potassium Tablets, 25 mg, covering 2012-09-18 to 2019-07-05. Get the full timeline:

Most recent: FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

See pricing